Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
DXC Technology
DXC
|
+$213M |
| 2 |
Altria Group
MO
|
+$206M |
| 3 |
ExxonMobil
XOM
|
+$105M |
| 4 |
Microsoft
MSFT
|
+$86.8M |
| 5 |
Meta Platforms (Facebook)
META
|
+$75.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
YHOO
Yahoo Inc
YHOO
|
+$403M |
| 2 |
Home Depot
HD
|
+$164M |
| 3 |
MJN
Mead Johnson Nutrition Company
MJN
|
+$160M |
| 4 |
Boeing
BA
|
+$127M |
| 5 |
Hewlett Packard
HPE
|
+$92.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.07% |
| 2 | Financials | 16.07% |
| 3 | Healthcare | 14.35% |
| 4 | Industrials | 10.62% |
| 5 | Consumer Discretionary | 9.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
MRTX
3401
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $372K | ﹤0.01% |
102,064
-16,924
| -14% | -$64.8K |
2015 Q1
9 quarters
|
|
3402
Global Self Storage
SELF
$57M
| $371K | ﹤0.01% |
74,849
| – | – |
2016 Q1
5 quarters
|
|
|
CBMG
3403
DELISTED
Cellular Biomedicine Group, Inc.
CBMG
| $371K | ﹤0.01% |
42,453
-18,993
| -31% | -$167K |
2014 Q4
10 quarters
|
|
|
HFBC
3404
DELISTED
HopFed Bancorp Inc
HFBC
| $371K | ﹤0.01% |
25,263
+1,706
| +7% | +$24.8K |
2013 Q2
16 quarters
|
|
|
FNBG
3405
DELISTED
FNB Bancorp Common Stock
FNBG
| $369K | ﹤0.01% |
+13,463
| New | +$373K |
2017 Q2
0 quarters
|
|
3406
Ballard Power Systems
BLDP
$586M
| $368K | ﹤0.01% |
127,924
+38,705
| +43% | +$109K |
2013 Q2
16 quarters
|
|
|
SAJA
3407
DELISTED
Sajan, Inc.
SAJA
| $368K | ﹤0.01% |
63,252
| – | – |
2015 Q3
7 quarters
|
|
3408
Aehr Test Systems
AEHR
$2.26B
| $367K | ﹤0.01% |
98,097
+5,335
| +6% | +$22.5K |
2013 Q2
16 quarters
|
|
|
AVDL
3409
DELISTED
Avadel Pharmaceuticals
AVDL
| $367K | ﹤0.01% |
33,326
+2,063
| +7% | +$20.7K |
2017 Q1
1 quarter
|
|
|
NAVB
3410
DELISTED
Navidea Biopharmaceuticals Inc.
NAVB
| $367K | ﹤0.01% |
36,010
| – | – |
2013 Q2
16 quarters
|
|
3411
Tecnoglass Holdings
TGLS
$1.66B
| $366K | ﹤0.01% |
39,275
-3,610
| -8% | -$36.3K |
2015 Q3
7 quarters
|
|
|
SITO
3412
DELISTED
SITO MOBILE, LTD
SITO
| $366K | ﹤0.01% |
98,656
+5,076
| +5% | +$17.1K |
2015 Q3
7 quarters
|
|
3413
Morgan Stanley Emerging Markets Debt Fund
MSD
$136M
| $365K | ﹤0.01% |
36,953
-150
| -0.4% | -$1.48K |
2014 Q3
11 quarters
|
|
3414
Philips
PHG
$24.9B
| $365K | ﹤0.01% |
13,431
-29
| -0.2% | -$760 |
2016 Q3
3 quarters
|
|
3415
Parke Bancorp
PKBK
$384M
| $365K | ﹤0.01% |
19,752
+6,651
| +51% | +$115K |
2017 Q1
1 quarter
|
|
|
CIE
3416
DELISTED
Cobalt International Energy, Inc
CIE
| $364K | ﹤0.01% |
147,424
-31,992
| -18% | -$151K |
2013 Q2
16 quarters
|
|
3417
First Guaranty Bancshares
FGBI
$135M
| $363K | ﹤0.01% |
+17,778
| New | +$340K |
2017 Q2
0 quarters
|
|
|
NH
3418
DELISTED
NantHealth, Inc
NH
| $363K | ﹤0.01% |
5,727
+811
| +16% | +$44.9K |
2016 Q2
4 quarters
|
|
3419
DELISTED
Cadence Bancorporation
CADE
| $363K | ﹤0.01% |
+16,629
| New | +$371K |
2017 Q2
0 quarters
|
|
|
CIZN
3420
DELISTED
Citizens Holding Co.
CIZN
| $362K | ﹤0.01% |
13,960
-18
| -0.1% | -$438 |
2015 Q3
7 quarters
|
|
|
NMRX
3421
DELISTED
Numerex Corp
NMRX
| $362K | ﹤0.01% |
73,465
-25,179
| -26% | -$112K |
2013 Q2
16 quarters
|
|
3422
Equinor
EQNR
$106B
| $361K | ﹤0.01% |
21,871
+7,571
| +53% | +$130K |
2013 Q2
16 quarters
|
|
3423
Palatin Technologies
PTN
$11.6M
| $361K | ﹤0.01% |
672
+133
| +25% | +$63.7K |
2014 Q1
13 quarters
|
|
|
INDT
3424
DELISTED
INDUS Realty Trust, Inc. (MD) Common Stock
INDT
| $360K | ﹤0.01% |
11,476
-479
| -4% | -$14.9K |
2013 Q2
16 quarters
|
|
3425
DELISTED
Cidara Therapeutics
CDTX
| $359K | ﹤0.01% |
2,400
-1,077
| -31% | -$149K |
2015 Q3
7 quarters
|
|
Similar funds
Geode Capital Management's Q2 2017 Portfolio in Review
As of Q2 2017, Geode Capital Management held 4,218 positions worth $254B, up 4.3% from $244B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Geode Capital Management's Q2 2017 filing shows 134 new, 2,755 increased, 887 reduced and 134 closed positions. Its largest new stake was DXC Technology: 3,214,073 shares worth $213M. The largest sale was Yahoo Inc, an estimated $403M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 16% a quarter earlier, followed by Financials and Healthcare.
- Geode Capital Management's largest Q2 2017 buy was DXC Technology: 3,214,073 shares worth $213M.
- Geode Capital Management added most to Altria Group in Q2 2017, an estimated $206M increase.
- Geode Capital Management's biggest Q2 2017 reduction was Home Depot, cutting an estimated $164M.
- Geode Capital Management fully exited Yahoo Inc in Q2 2017, selling an estimated $403M.
- Geode Capital Management's ten largest holdings make up 16% of its $254B portfolio in Q2 2017.
- Geode Capital Management opened 134 new positions and closed 134 in Q2 2017.
- Geode Capital Management's portfolio value rose 4.3% quarter-over-quarter to $254B.
Based on Geode Capital Management's 13F filing for Q2 2017, filed 14 Aug 2017.